|
Breath control techniques
|
|
Gating
|
20
|
|
Active breathing control
|
7
|
|
Free Breathing
|
4
|
|
Prescriptions
|
|
5–7.5 GyE X 8–10 Fx
|
12
|
|
4–5 GyE X 15–16 Fx
|
3
|
|
2.25–3.5 GyE X 22–31 Fx
|
16
|
|
BED10 (GyE), median (range)
|
96 (75–119)
|
|
Radiation techniques/sources
|
|
PRT only
|
6
|
|
PRT + CIRT boost
|
6
|
|
CIRT only
|
19a
|
|
Chemotherapy
|
6
|
|
1 cycle (neoadjuvant of pemetrexed+ cisplatin)
|
1
|
|
3 cycles (concurrent of Taxol+ cisplatin)
|
1
|
|
4 cycles (neoadjuvant of etoposide+ cisplatin)
|
1
|
|
4 cycles (neoadjuvant of pemetrexed X 3+ docetaxel X 1)
|
1
|
|
5 cycles (neoadjuvant of gemcitabine+ cisplatin X 3 + concurrent of Taxol+ cisplatin X 2)
|
1
|
|
6 cycles (neoadjuvant of gemcitabine+ cisplatin)
|
1
|
